REPORT: Moderna Admits Jab Recipients Last Year Twice as Likely To Get COVID-19 Breakthrough Infection

Share The Story

The time for prepping the U.S. population for boosters is here.

As I like to call them, the ‘Triple McJab.’

Moderna conducted research on the efficacy of its two-dose series.

The results were troubling for those who received the experimental jabs in 2020.

Researchers compared the number of breakthrough infections for those who received the jabs between July 2020-December 2020 to those injected between December 2020-March 2021.

And the results exposed the pathetic efficacy of the injections.

Moderna concluded that those injected in 2020 were twice as likely to contract COVID-19 compared to those injected in 2021.

Their solution?

More shots!

They advocated for fully vaccinated to receive the booster 6-8 months after their 2nd dose.

It’s the same trap we saw unfold in Israel.

Eventually, you won’t be ‘fully vaccinated’ unless you receive the booster.

That’s my prediction for what’s to come in America.

It’s further indication that these experimental jabs are an abysmal failure.

And they should all get tossed in the trash.

Here’s the latest:





Daily Mail reported:

Moderna Inc says people who received its COVID-19 vaccine last year are nearly twice as likely to get a breakthrough infection compared to those recently vaccinated.

Breakthrough cases occur when people contract the disease 14 days or more after receiving their final dose of the shot.

New data published on Wednesday found 88 breakthrough cases of COVID-19 among Americans vaccinated from December 2020 to March 2021.

Comparatively, there were 162 cases – 1.8 times as many – among those vaccinated between July 2020 and December 2020.

The Cambridge, Massachusetts-based company also reported 13 severe cases among the early vaccination group compared to six in the later group.

What’s more, there were three Covid hospitalizations and two deaths in the group vaccinated last year compared to no hospitalizations or deaths in the group vaccinated in winter 2020 and spring 2021.

Moderna says the data provide evidence for giving booster doses to fully vaccinated people.

The data looked at people who participated in Moderna’s Phase 3 COVE study from last year and those who received the vaccine after it received emergency use authorization from the U.S. Food and Drug Administration (FDA).

Of 14,746 who received the vaccine between July 2020 and December 2020, there were 162 breakthrough Covid cases.

By comparison, there were 88 breakthrough cases among 11,431 who received the vaccine from December 2020 to March 2021.

Researchers say this means there is a 36 percent reduced protection from those who received their first dose 13 months ago compared to those given their initial shot eight months ago.

For both groups, more cases were seen among younger adults.

From FOX News:

In a statement issued along with the data, Moderna CEO Stéphane Bancel insisted that the data “supports the need for a booster” shot.

“It is promising to see clinical and real-world evidence adding to the growing body of data on the effectiveness of the Moderna COVID-19 vaccine,” Bancel said of the unpublished analysis. “The increased risk of breakthrough infections in COVE study participants who were vaccinated last year compared to more recently illustrates the impact of waning immunity and supports the need for a booster to maintain high levels of protection.

Moderna has also requested authorization from the U.S. Food and Drug Administration for a third-dose booster shot, which will be one-half the dose of its existing vaccine.

For those who already took the two-dose Moderna series, they want you as a life-long Big Pharma subscriber.

Boosters every 6-8 months for life.

Unless you say no.

Share The Story

Add Comment